Priya Mitty Ryali, MBA

Senior Director, Head Of Clinical Operations at ReCode Therapeutics

Priya Mitty Ryali, MBA has over 17 years of experience in the healthcare industry. Priya Mitty began their career in 2004 as a Recovery Manufacturing Sciences and Technology Intern at Genentech. In 2005, they moved to Amgen as a Research Associate. From 2011 to 2012, they worked as a Clinical Trial Specialist at Janssen Alzheimer Immunotherapy. Priya Mitty then joined Gilead Sciences as a Senior Clinical Trial Management Associate/Study Lead from 2012 to 2017. In 2017, they moved to Ultragenyx Pharmaceutical Inc. as a Senior Clinical Trial Manager/Program Lead. Priya Mitty then worked at Natera as a Senior Clinical Trial Manager/Program Lead from 2019 to 2020. In 2021, they joined Alector as a Director Clinical Operations and a Clinical Operations Program Lead. Currently, they are working as a Director Clinical Operations at ReCode Therapeutics since 2022.

Priya Mitty Ryali holds a Bachelor of Science in Biotechnology from the University of California, Davis and a Masters of Business Administration from Santa Clara University. Priya Mitty also graduated from Saint Francis High School.

Location

San Carlos, United States

Links

Previous companies


Org chart


Teams


Offices


ReCode Therapeutics

1 followers

ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases.


Industries

Employees

51-200

Links